SCHEMBL7707827

SCHEMBL7707827

COC(=O)C1C=c2c(c3c(n2Cc2cc4c(cc2Cl)OCO4)C(=O)CCC3)=CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC22A12 Q96S37 1/20 0.32
MCHR1 Q99705 1/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2C9 P11712 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
DRD2 P14416 1/20 0.31
OPRM1 P35372 1/20 0.31
DRD3 P35462 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
OPRL1 P41146 1/20 0.31
EDNRA P25101 1/20 0.31
BRD4 O60885 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7707829 0.74 KDM4E (0.35) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL7420612 0.71 ALDH1A1 (0.44) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL7426960 0.67 ALDH1A1 (0.51) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL7421878 0.66 KDM4E (0.41) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL7474496 0.66 MEN1 (0.43) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL7473906 0.61 ALDH1A1 (0.43) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL7476678 0.60 SLC22A12 (0.39) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL8843367 0.56 CYP3A4 (0.44) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL6306001 0.55 MAPT (0.40) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12
SCHEMBL8215543 0.55 CYP1A2 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed